MétaCan
Menu
Back to cohort
Record W4212798424 · doi:10.1016/j.jcmgh.2022.02.011

Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells

2022· article· en· W4212798424 on OpenAlexafffund
Maegan E. Chen, Setareh Malekian Naeini, Arjuna Srikrishnaraj, Daniel J. Drucker, Zivit Fesler, Patricia L. Brubaker

Bibliographic record

VenueCellular and Molecular Gastroenterology and Hepatology · 2022
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsUniversity of TorontoMuscular Dystrophy Canada
FundersBanting and Best Diabetes Centre, University of TorontoCanadian Institutes of Health ResearchNovo NordiskNovo Nordisk FondenUniversity of TorontoLunds UniversitetCanadian Association of Gastroenterology
KeywordsLGR5Stem cellBiologyCell cycleGlucagon-like peptide-2Internal medicineEndocrinologyIntestinal epitheliumCell biologyMolecular biologyCellCancer stem cellEpitheliumBiochemistryMedicinePeptide

Abstract

fetched live from OpenAlex

Background & Aims Leucine-rich repeat-containing G-protein–coupled receptor-5 (Lgr5)+/olfactomedin-4 (Olfm4)+ intestinal stem cells (ISCs) in the crypt base are crucial for homeostatic maintenance of the epithelium. The gut hormone, glucagon-like peptide-2 1–33 (GLP-2), stimulates intestinal proliferation and growth; however, the actions of GLP-2 on the Lgr5+ ISCs remain unclear. The aim of this study was to determine whether and how GLP-2 regulates Lgr5+ ISC cell-cycle dynamics and numbers. Methods Lgr5-Enhanced green-fluorescent protein - internal ribosome entry site – Cre recombinase – estrogen receptor T2 (eGFP-IRES-creERT2) mice were acutely administered human Glycine 2 (Gly2)-GLP-2, or the GLP-2–receptor antagonist, GLP-2 3–33 . Intestinal epithelial insulin-like growth factor-1–receptor knockout and control mice were treated chronically with human Gly2 (hGly2)–GLP-2. Cell-cycle parameters were determined by 5-Ethynyl-2'-deoxyuridine (EdU), bromodeoxyuridine, antibody #Ki67, and phospho-histone 3 labeling and cell-cycle gene expression. Results Acute hGly2–GLP-2 treatment increased the proportion of eGFP+EdU+/OLFM4+EdU+ cells by 11% to 22% ( P < .05), without affecting other cell-cycle markers. hGly2–GLP-2 treatment also increased the ratio of eGFP+ cells in early to late S-phase by 97% ( P < .001), and increased the proportion of eGFP+ cells entering S-phase by 218% ( P < .001). hGly2–GLP-2 treatment induced jejunal expression of genes involved in cell-cycle regulation ( P < .05), and increased expression of Mcm3 in the Lgr5 -expressing cells by 122% ( P < .05). Conversely, GLP-2 3–33 reduced the proportion of eGFP+EdU+ cells by 27% ( P < .05), as well as the expression of jejunal cell-cycle genes ( P < .05). Finally, chronic hGly2–GLP-2 treatment increased the number of OLFM4+ cells/crypt ( P < .05), in an intestinal epithelial insulin-like growth factor-1–receptor–dependent manner. Conclusions These findings expand the actions of GLP-2 to encompass acute stimulation of Lgr5+ ISC S-phase entry through the GLP-2R, and chronic induction of Lgr5+ ISC expansion through downstream intestinal insulin-like growth factor-1 signaling.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.233
Teacher spread0.224 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueCellular and Molecular Gastroenterology and HepatologySame topicDiabetes Treatment and ManagementFrench-language works237,207